These results suggest IL-33/ST2 signaling plays a role in promoting the effector and cytotoxic T cell responses and enhancing the CNS resident immune response, which combined contributes to the neuropathology and cognitive deficits associated with ECM. Here, IL1RL1 is linked to Cognitive impairment.